MiCo BioMed, an in-vitro diagnostic medical device maker, said Tuesday that it completed the clinical trial of the monkeypox testing kit and applied for its export approval to the Ministry of Food and Drug Safety (MFDS).In July, the company conducted a clinical trial of a monkeypox PCR testing kit (
Pharmaceutical experts repeatedly said SK Bioscience’s Covid-19 vaccine SKYCovione needed additional safety review during the regulator’s marketing approval process, minutes of a drug review panel showed.The Ministry of Food and Drug Safety recently disclosed the minutes of the Central Pharmaceutica
SK Biopharmaceuticals’ epilepsy drug Cenobamate will soon be reviewed for approval in Canada and Israel.Paladin Labs, a subsidiary of SK Biopharma’s partner company Endo International, sent new drug submission (NDS) for the innovative novel drug for epilepsy to Health Canada in June.If the Canadian
The Korea Health Industry Development Institute (KHIDI) said on Tuesday that it would hold the "2022 Seoul Biomedical International Conference (2022 SIBC)" on Sept. 29 at the Seoul Metropolitan Government’s new office.City Hall hosts and the state agency organizes the sixth annual conference.The con
Korea reported four deaths from Covid-19 among children aged younger than 10 in July alone, government data showed.The total number of child deaths from Covid-19 has gone up to 27, as of midnight Sunday.According to the Korea Disease Control and Prevention Agency (KDCA), two children aged nine or yo
Genematrix said Monday that it obtained the Conformité Européene In-vitro diagnostic (CE-IVD) device certification for its new Neoflex TB/NTM-5 detection kit, a new respiratory diagnostic product.The kit can identify one type of mycobacterium tuberculosis (TB) and five different types of non-tubercu
Pangen Biotech announced Monday that it signed a joint development agreement with Moogene Medi to develop a protein treatment using lipid nanoparticles (LNPs).The two companies also applied for a patent on “LNPs for protein transfer” in July.LNPs are transmitter substances of mRNA Covid-19 vaccine d
MedPacto announced Monday that it received green light from the U.S. FDA to test Vactosertib as a solo therapy for recurrent and intractable osteosarcoma patients in a phase 1/2 trial.The study will be on 54 patients aged 14 or older who suffer from recurrent or intractable osteosarcoma and carried
Cellid, a Korean bio-venture, will conduct a Covid-19 vaccine study in Kenya and Tanzania, a company official said.“In the near future, we will apply for an investigational new drug (IND) clinical trial in Kenya and Tanzania, jointly with the International Vaccine Institute (IVI),” the official told
Novo Nordisk is facing difficulties to replace the existing drug Saxenda (liraglutide) with a new drug Wegovy (semaglutide) in the obesity treatment market due to manufacturing issues.On Thursday, the Danish multinational drugmaker said in an IR meeting for second-quarter earnings that it would be d
The Lithuanian Biotechnology Association (LBTA) said on Friday that they signed a memorandum of understanding (MOU) with Korea Biotechnology Industry (Korea BIO) to establish stronger cooperation with Korean bio-companies in the field of high value-added technologies.In an interview with Korea Biome
Macrogen, a company specializing in precision medicine biotechnology, said on Monday that it is expanding its multiomics business by providing domestic and foreign protein analysis services.Multiomics is a high-level analytical technique that integrates genomic, transcriptome, and proteome data, and
KT, the second-largest telco in Korea, has been accelerating its entry into the digital healthcare sector recently. Now, the company is seeking to expand its influence to lead the local healthcare ecosystem.“The healthcare industry is expanding from diagnosis and treatment to prevention and manageme
The Ministry of Food and Drug Safety said that it has begun a preliminary review of Comirnaty, Pfizer’s Covid-19 vaccine developed to fight the Omicron variant.Pfizer Korea applied to the ministry on Friday for a preliminary review on clinical trial data of the Omicron-targeting Comirnaty vaccine.Th
Huinno, a digital healthcare firm, said Friday the Ministry of Food and Drug Safety (MFDS) chose the company to provide technical support for a national project to adopt the international standards on the quality control of the latest medical devices.The project is jointly organized by Seoul Nationa
Bukwang Pharmaceutical its subsidiary Dyna Therapeutics obtained a composition patent for SOL-804, a prostate cancer drug candidate, in Korea and Japan.With the additional two patent registrations, Dyna has completed the patent registration in 32 countries including the U.S., Australia, Mexico, and
Celltrion Healthcare said it has officially begun preparing to directly market its drugs in the U.S. by acquiring Celltrion USA from Celltrion.Celltrion Healthcare and Celltrion believe the acquisition will help maximize profits for both companies by strengthening each company's core competency and
HLB Life Science, which owns rights to market Jiangsu Hengrui Medicine’s anticancer drug pyrotinib in Korea, said it would expand new pipelines on the back of the recent success of a phase 3 pyrotinib trial.Jiangsu Hengrui announced that the phase 3 clinical trial of pyrotinib met the primary endpoi
Kyung Hee University Medical Center (KHMC) said it ranked 10th in the 2021 Inpatient Experience Evaluation conducted by the Health Insurance Review and Assessment Service (HIRA) on 359 general hospitals nationwide.According to the hospital, KHMC received a score of 88.6, ranking tenth among all gene
The Ministry of Health and Welfare recently changed the official English name of “Oriental medical doctor” to “doctor of Korean medicine,” causing a strong backlash from the medical community.Doctors said the new name could be misleading because English-speaking people could confuse Western medical